Advances in cardiac cellular electrophysiology - Relevance for clinical translation. Ravens U, Goette A. Herzschrittmacherther Elektrophysiol.
2018 Jan 25. doi: 10.1007/s00399-018-0556-0. [Epub ahead of print] No abstract available.


Atrial fibrillation and stroke risk factors induce decline in creatinine clearance: Is there a specific "fibrillatory kidney disease"? Goette A. Int J Cardiol. 2018 Feb 15;253:82-83. doi: 10.1016/j.ijcard.2017.11.052.
No abstract available.


Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. Kotecha D, Breithardt G, Camm AJ, Lip GYH, Schotten U, Ahlsson A, Arnar D, Atar D, Auricchio A, Bax J, Benussi S, Blomstrom-Lundqvist C, Borggrefe M, Boriani G, Brandes A, Calkins H,
Casadei B, Castellá M, Chua W, Crijns H, Dobrev D, Fabritz L, Feuring M, Freedman B, Gerth A, Goette A, Guasch E, Haase D, Hatem S, Haeusler KG, Heidbuchel H, Hendriks J, Hunter C, Kääb S, Kespohl S, Landmesser U, Lane DA, Lewalter T, Mont L, Nabauer M, Nielsen JC, Oeff M, Oldgren J, Oto A, Pison L, Potpara T, Ravens U, Richard-Lordereau I, Rienstra M, Savelieva I, Schnabel R, Sinner MF, Sommer P, Themistoclakis S, Van Gelder IC, Vardas PE, Verma A, Wakili R, Weber E, Werring D, Willems S,
Ziegler A, Hindricks G, Kirchhof P. Europace. 2018 Jan 2. doi:
10.1093/europace/eux318. [Epub ahead of print]


Atrial thrombogenesis in atrial fibrillation : Results from atrial fibrillation models and AF-patients. Bukowska A, Hammwöhner M, Corradi D, Mahardhika W, Goette A. Herzschrittmacherther Elektrophysiol. 2017 Dec 12. doi: 10.1007/s00399-017-0543-x. [Epub ahead of print] Review.


Progressive impairment of atrial myocyte function during left ventricular hypertrophy and heart failure. Pluteanu F, Nikonova Y, Holzapfel A, Herzog B, Scherer A, Preisenberger J, Pla?ki? J, Scheer K,
Ivanova T, Bukowska A, Goette A, Kockskämper J. J Mol Cell Cardiol. 2017
Dec 2;114:253-263. doi: 10.1016/j.yjmcc.2017.11.020. [Epub ahead of print]


Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS Undergoing cardiovErsion of Atrial
Fibrillation [ENSURE-AF] Study). Lip GYH, Merino JL, Dan GA, Themistoclakis S, Ellenbogen KA, De Caterina R, Goudev A, Jin J, Melino M, Winters SM, Goette A. Am J Cardiol. 2018 Jan 15;121(2):193-198. doi: 10.1016/j.amjcard.2017.10.008. Epub 2017 Nov 20.


Incidence and costs of cardiac device infections: retrospective analysis using German health claims data. Ludwig S, Theis C, Brown B, Witthohn A, Lux W, Goette A. J Comp Eff Res. 2017 Nov 14. doi:
10.2217/cer-2017-0080. [Epub ahead of print]


The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. Lip GYH, Al-Saady N, Ezekowitz MD, Banach M, Goette A. Am Heart J. 2017 Nov;193:16-22. doi:
10.1016/j.ahj.2017.07.010. Epub 2017 Jul 20.


Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS). Sarkozy A, De Potter T, Heidbuchel H, Ernst S, Kosiuk J, Vano E, Picano E, Arbelo E, Tedrow U; ESC Scientific Document Group. Europace. 2017 Dec 1;19(12):1909-1922. doi: 10.1093/europace/eux252. No abstract available.


Why is there still undertreatment with oral anticoagulants in elderly high risk patients with AF? Goette A. Int J Cardiol. 2017 Dec 15;249:247-248. doi: 10.1016/j.ijcard.2017.08.034. No abstract
available.


Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE). Mairesse GH, Moran P, Van Gelder IC, Elsner C, Rosenqvist M, Mant J, Banerjee A, Gorenek B, Brachmann J, Varma N, Glotz de Lima G, Kalman J, Claes N, Lobban T, Lane D, Lip GYH, Boriani G; ESC Scientific Document Group.
Europace. 2017 Oct 1;19(10):1589-1623. doi: 10.1093/europace/eux177. No abstract available.


Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Gorenek B Chair, Bax J, Boriani G, Chen SA, Dagres N, Glotzer TV, Healey JS, Israel CW, Kudaiberdieva G, Levin LÅ, Lip GYH, Martin D, Okumura K, Svendsen JH, Tse HF, Botto GL Co-Chair; ESC Scientific Document Group. Europace. 2017 Sep 1;19(9):1556-1578. doi: 10.1093/europace/eux163. No abstract available.


The safety of edoxaban for treating atrial fibrillation. Hammwöhner M, Goette A. Expert Opin Drug Saf. 2017 Nov;16(11):1295-1303. doi: 10.1080/14740338.2017.1372418. Epub 2017 Sep 18. Review


Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group. N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.


Practical Implementation of Anticoagulation Strategy for Patients Undergoing Cardioversion of Atrial Fibrillation. Goette A, Heidbuchel H. Arrhythm Electrophysiol Rev. 2017 Jun;6(2):50-54. doi:
10.15420/aer.2017:3:2.


CREM-transgene mice: An animal model of atrial fibrillation and thrombogenesis. Bukowska A, Felgendreher M, Scholz B, Wolke C, Schulte JS, Fehrmann E, Wardelmann E, Seidl MD, Lendeckel U, Himmler K, Gardemann A, Goette A, Müller FU. Thromb Res. 2017 Aug 1. pii: S0049-3848(17)30443-7. doi: 10.1016/j.thromres.2017.07.033. [Epub ahead of print]


Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.
Kirchhof P, Blank BF, Calvert M, Camm AJ, Chlouverakis G, Diener HC, Goette A, Huening A, Lip GYH, Simantirakis E, Vardas P. Am Heart J. 2017 Aug;190:12-18. doi: 10.1016/j.ahj.2017.04.015. Epub 2017 May 3.


Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial). Lip GYH, Al-Saady N, Jin J, Sun M, Melino M, Winters SM, Zamoryakhin D, Goette A. Am J Cardiol. 2017 Sep 1;120(5):792-796. doi: 10.1016/j.amjcard.2017.06.005. Epub 2017 Jun 15.


Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men. Bukowska A, Spiller L, Wolke C, Lendeckel U, Weinert S, Hoffmann J, Bornfleth P, Kutschka I, Gardemann A, Isermann B, Goette A. Exp Biol Med (Maywood). 2017 Aug;242(14):1412-1423. doi: 10.1177/1535370217718808. Epub 2017 Jun 29.


European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Gorenek B, Pelliccia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI, Van Gelder IC, Halle M, Kudaiberdieva G, Lane DA, Larsen TB, Lip GY, Løchen ML, Marín F, Niebauer J, Sanders P, Tokgozoglu L, Vos MA, Van Wagoner DR, Fauchier L, Savelieva I, Goette A, Agewall S, Chiang CE, Figueiredo M, Stiles M, Dickfeld T, Patton K, Piepoli M, Corra U, Marques-Vidal PM, Faggiano P, Schmid JP, Abreu A. Europace. 2017 Feb 1;19(2):190-225. doi:
10.1093/europace/euw242. No abstract available.


EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: definition, characterization, and clinical implication. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D'Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Van Wagoner D, Nattel S; Document Reviewers:, Centurion OA, Kuck KH, Patton KK, Sapp JL, Stiles M, Svendsen JH, Upadhyay GA; Review coordinator:, Shantsila A. Europace. 2016 Jul 8. pii: euw161. [Epub ahead of print]

Predictors of sinus rhythm after electrical cardioversion of atrial fibrillation: results from a data mining project on the Flec-SL trial data set
. Oto E, Okutucu S, Katircioglu-Öztürk D, Güvenir HA, Karaagaoglu E, Borggrefe M, Breithardt G, Goette A, Ravens U, Steinbeck G, Wegscheider K, Oto A, Kirchhof P. Europace. 2016 Jul 4. pii: euw144. [Epub ahead of print]

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication
. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D'Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Wagoner DV, Nattel S. Heart Rhythm. 2016 Jun 10. pii: S1547-5271(16)30376-9. doi: 10.1016/j.hrthm.2016.05.028. [Epub ahead of print]

[AFNET. A translational research network develops into an academic research organization]
. Kirchhof P, Goette A, Näbauer M, Schotten U. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Apr;59(4):514-22. doi: 10.1007/s00103-016-2323-x. German.

EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. Donal E, Lip GY, Galderisi M, Goette A, Shah D, Marwan M, Lederlin M, Mondillo S, Edvardsen T, Sitges M, Grapsa J, Garbi M, Senior R, Gimelli A, Potpara TS, Van Gelder IC, Gorenek B, Mabo P, Lancellotti P, Kuck KH, Popescu BA, Hindricks G, Habib G, Cosyns B, Delgado V, Haugaa KH, Muraru D, Nieman K, Cohen A. Eur Heart J Cardiovasc Imaging. 2016 Apr;17(4):355-83. doi: 10.1093/ehjci/jev354. Epub 2016 Feb 9.

A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
. Kirchhof P, Breithardt G, Bax J, Benninger G, Blomstrom-Lundqvist C, Boriani G, Brandes A, Brown H, Brueckmann M, Calkins H, Calvert M, Christoffels V, Crijns H, Dobrev D, Ellinor P, Fabritz L, Fetsch T, Freedman SB, Gerth A, Goette A, Guasch E, Hack G, Haegeli L, Hatem S, Haeusler KG, Heidbüchel H, Heinrich-Nols J, Hidden-Lucet F, Hindricks G, Juul-Möller S, Kääb S, Kappenberger L, Kespohl S, Kotecha D, Lane DA, Leute A, Lewalter T, Meyer R, Mont L, Münzel F, Nabauer M, Nielsen JC, Oeff M, Oldgren J, Oto A, Piccini JP, Pilmeyer A, Potpara T, Ravens U, Reinecke H, Rostock T, Rustige J, Savelieva I, Schnabel R, Schotten U, Schwichtenberg L, Sinner MF, Steinbeck G, Stoll M, Tavazzi L, Themistoclakis S, Tse HF, Van Gelder IC, Vardas PE, Varpula T, Vincent A, Werring D, Willems S, Ziegler A, Lip GY, Camm AJ. Europace. 2016 Jan;18(1):37-50. doi: 10.1093/europace/euv304. Epub 2015 Oct 18. Review.

The European Network for Translational Research in Atrial Fibrillation (EUTRAF): objectives and initial results
. Schotten U, Hatem S, Ravens U, Jaïs P, Müller FU, Goette A, Rohr S, Antoons G, Pieske B, Scherr D, Oto A, Casadei B, Verheule S, Cartlidge D, Steinmeyer K, Götsche T, Dobrev D, Kockskämper J, Lendeckel U, Fabritz L, Kirchhof P, Camm AJ; EUTRAF investigators. Europace. 2015 Oct;17(10):1457-66. doi: 10.1093/europace/euv252. Epub 2015 Sep 12. Review.

The Impact of Novel Anticoagulants: Should All AF Patients Now Be Anticoagulated?
Hammwöhner M, Goette A. J Cardiovasc Pharmacol. 2015 Dec;66(6):530-9. doi: 10.1097/FJC.0000000000000297.

Dronedarone does not affect infarct volume as assessed by magnetic resonance imaging in a porcine model of myocardial infarction. Linke J, Utpatel K, Wolke C, Evert M, Kühn JP, Bukowska A, Goette A, Lendeckel U, Peters B. Mol Med Rep. 2015 Oct;12(4):5169-78. doi: 10.3892/mmr.2015.4077. Epub 2015 Jul 13.

A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. Lip GY, Merino J, Ezekowitz M, Ellenbogen K, Zamoryakhin D, Lanz H, Jin J, Al-Saadi N, Mercuri M, Goette A. Am Heart J. 2015 May;169(5):597-604.e5. doi: 10.1016/j.ahj.2015.02.009. Epub 2015 Feb 21.

Atrial fibrillation and rapid acute pacing regulate adipocyte/adipositas-related gene expression in the atria.
Chilukoti RK, Giese A, Malenke W, Homuth G, Bukowska A, Goette A, Felix SB, Kanaan J, Wollert HG, Evert K, Verheule S, Jais P, Hatem SN, Lendeckel U, Wolke C. Int J Cardiol. 2015;187:604-13. doi: 10.1016/j.ijcard.2015.03.072. Epub 2015 Mar 23.

Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: a longitudinal analysis--data from the German Competence Network on Atrial Fibrillation.
von Eisenhart Rothe A, Hutt F, Baumert J, Breithardt G, Goette A, Kirchhof P, Ladwig KH. Europace. 2015 Sep;17(9):1354-62. doi: 10.1093/europace/euv018. Epub 2015 Mar 29.

One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care.
Goette A, Benninger G, Pittrow D, Paar WD, von Stritzky B, Bosch RF. Herzschrittmacherther Elektrophysiol. 2015 Jun;26(2):148-54. doi: 10.1007/s00399-015-0360-z. Epub 2015 Mar 8.

Early subcellular Ca2+ remodelling and increased propensity for Ca2+ alternans in left atrial myocytes from hypertensive rats.
Pluteanu F, Heß J, Plackic J, Nikonova Y, Preisenberger J, Bukowska A, Schotten U, Rinne A, Kienitz MC, Schäfer MK, Weihe E, Goette A, Kockskämper J. Cardiovasc Res. 2015 Apr 1;106(1):87-97. doi: 10.1093/cvr/cvv045. Epub 2015 Feb 17.

Update on management of cardiac arrhythmias in acute coronary syndromes. Willich T, Goette A. Minerva Cardioangiol. 2015 Apr;63(2):121-33. Epub 2015 Jan 22.

Redox control of cardiac remodeling in atrial fibrillation. Wolke C, Bukowska A, Goette A, Lendeckel U. Biochim Biophys Acta. 2015 Aug;1850(8):1555-65. doi: 10.1016/j.bbagen.2014.12.012. Epub 2014 Dec 13. Review.

Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, Brachmann J, Lewalter T, Goette A, Block M, Kautzner J, Sack S, Husser D, Piorkowski C, Søgaard P; IN-TIME study group. Lancet. 2014 Aug 16;384(9943):583-90.

Upstream therapy for atrial fibrillation. Goette A, Hammwöhner M, Bukowska A Herzschrittmacherther Elektrophysiol. 2014 Mar;25(1):33-40.

Bradycardic arrhythmias. Willich T, Goette A. Dtsch Med Wochenschr. 2014 Feb;139(8):381-6.

Bradycardic arrhythmias--part 1: pathophysiology and symptoms. Willich T, Goette A. Dtsch Med Wochenschr. 2014 Feb;139(7):329-33.

Depression in paroxysmal and persistent atrial fibrillation patients: a cross-sectional comparison of patients enroled in two large clinical trials. von Eisenhart Rothe AF, Goette A, Kirchhof P, Breithardt G, Limbourg T, Calvert M, Baumert J, Ladwig KH. Europace. 2014 Jun;16(6):812-9.

PPAR-? activation limits angiotensin II-mediated atrial remodeling: one drug fits all AF patients? Lendeckel U, Wolke C, Goette A. J Mol Cell Cardiol. 2014 Jan;66:165-6.

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61176-4/abstract von Prof Gerhard Hindricks, Prof Milos Taborsky, Prof Michael Glikson, Ullus Heinrich, Prof Burghard Schumacher, Prof Amos Katz, Prof Johannes Brachmann, Prof Thorsten Lewalter, Prof Andreas Goette, Prof Michael Block, Prof Josef Kautzner, Prof Stefan Sack, Prof Daniela Husser, Christopher Piorkowski, Prof Peter Søgaard, for the IN-TIME study group. The Lancet, Volume 384, Issue 9943, Pages 583 - 590, 16 August 2014.

Depression in paroxysmal and persistent atrial fibrillation patients: a cross-sectional comparison of patients enroled in two large clinical trials. von Eisenhart Rothe AF, Goette A, Kirchhof P, Breithardt G, Limbourg T, Calvert M, Baumert J, Ladwig KH.Europace. 2013 Dec 18. [Epub ahead of print]
 
PPAR-? activation limits angiotensin II-mediated atrial remodeling: One drug fits all AF patients?
Lendeckel U, Wolke C, Goette A. J Mol Cell Cardiol. 2013 Dec 7;66C:165-166. doi: 10.1016/j.yjmcc.2013.12.001. [Epub ahead of print] No abstract available.
 
Upstream therapy for atrial fibrillation in heart failure. Goette A.Heart Fail Clin. 2013 Oct;9(4):417-25, viii. doi: 10.1016/j.hfc.2013.07.010. Epub 2013 Aug 12.
 
 
Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue. Bukowska A, Zacharias I, Weinert S, Skopp K, Hartmann C, Huth C, Goette A. Eur J Pharmacol. 2013 Oct 15;718(1-3):114-23. doi: 10.1016/j.ejphar.2013.09.006. Epub 2013 Sep 13.
 
 
Predictors of discordance between physicians' and patients' appraisals of health-related quality of life in atrial fibrillation patients: findings from the Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial.
von Eisenhart Rothe A, Bielitzer M, Meinertz T, Limbourg T, Ladwig KH, Goette A. Am Heart J. 2013 Sep;166(3):589-96. doi: 10.1016/j.ahj.2013.05.020. Epub 2013 Jul 10.
 
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial. Maggioni AP, Greene SJ, Fonarow GC, Böhm M, Zannad F, Solomon SD, Lewis EF, Baschiera F, Hua TA, Gimpelewicz CR, Lesogor A, Gheorghiade M; ASTRONAUT Investigators and Coordinators. Eur Heart J. 2013 Oct;34(40):3117-27. doi: 10.1093/eurheartj/eht342. Epub 2013 Sep 2.
 
Epsilon waves in giant-cell myocarditis. Vollmann D, Goette A, Kandolf R, Hasenfuss G.
Eur Heart J. 2014 Jan;35(1):9. doi: 10.1093/eurheartj/eht338. Epub 2013 Aug 29. No abstract available.
 
Potential role of telemedical service centers in managing remote monitoring data transmitted daily by cardiac implantable electronic devices: results of the early detection of cardiovascular events in device patients with heart failure (detecT-Pilot) study. Müller A, Goette A, Perings C, Nägele H, Konorza T, Spitzer W, Schulz SS, von Bary C, Hoffmann M, Albani M, Sack S, Niederlöhner A, Lewalter T. Telemed J E Health. 2013 Jun;19(6):460-6. doi: 10.1089/tmj.2012.0154. Epub 2013 Apr 9.
 
Actualización de las guías de la Sociedad Europea de Cardiología (ESC) para el manejo de la fibrilación auricular de 2010 Elaborada en colaboración con la Asociación Europea del Ritmo Cardiaco.
tores/miembros del Grupo de Trabajo, Camm AJ, Lip GY, Caterina RD, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; Comité de la ESC de Guías para la Práctica Clínica (CGPC), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Anton Sirnes P, Tendera M, Torbicki A, Vahanian A, Windecker S; Revisores del documento, Vardas P, Al-Attar N, Alfieri O, Angelini A, Blömstrom-Lundqvist C, Colonna P, De Sutter J, Ernst S, Goette A, Gorenek B, Hatala R, Heidbüchel H, Heldal M, Dalby Kristensen S, Kolh P, Le Heuzey JY, Mavrakis H, Mont L, Perrone Filardi P, Ponikowski P, Prendergast B, Rutten FH, Schotten U, Van Gelder IC, Verheugt FW.
Rev Esp Cardiol. 2013 Jan;66(1):54.e1-54.e24. doi: 10.1016/j.recesp.2012.11.001. Epub 2012 Dec 25. English, Spanish. No abstract available.
 
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
Gheorghiade M, Böhm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F, Solomon SD, Baschiera F, Botha J, Hua TA, Gimpelewicz CR, Jaumont X, Lesogor A, Maggioni AP; ASTRONAUT Investigators and Coordinators.
JAMA. 2013 Mar 20;309(11):1125-35. doi: 10.1001/jama.2013.1954. Erratum in: JAMA. 2013 Apr 10;309(14):1461.
 
Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo.
Chilukoti RK, Mostertz J, Bukowska A, Aderkast C, Felix SB, Busch M, Völker U, Goette A, Wolke C, Homuth G, Lendeckel U. Int J Cardiol. 2013 Oct 3;168(3):2100-8. doi: 10.1016/j.ijcard.2013.01.007. Epub 2013 Feb 12.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: Key trial findings and clinical implications. Goette A. Trends Cardiovasc Med. 2013 Jan 10. doi:pii: S1050-1738(12)00400-8. 10.1016/j.tcm.2012.10.001. [Epub ahead of print]

Enzymatic activity of DPIV and renin-angiotensin system (RAS) proteases in patients with left ventricular dysfunction and primary prevention implantable cardioverter/defibrillator (ICD). Lehmann HI, Wolke C, Malenke W, Röhl FW, Hammwöhner M, Bukowska A, Lendeckel U, Goette A. Int J Cardiol. 2012 Oct 10. doi:pii: S0167-5273(12)01189-8. 10.1016/j.ijcard.2012.09.083. [Epub ahead of print]

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines-CPG; Document Reviewers. Europace. 2012 Oct;14(10):1385-413. Epub 2012 Aug 24.

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Vardas P, Al-Attar N, Alfieri O, Angelini A, Blömstrom-Lundqvist C, Colonna P, De Sutter J, Ernst S, Goette A, Gorenek B, Hatala R, Heidbüchel H, Heldal M, Kristensen SD, Kolh P, Le Heuzey JY, Mavrakis H, Mont L, Filardi PP, Ponikowski P, Prendergast B, Rutten FH, Schotten U, Van Gelder IC, Verheugt FW. Eur Heart J. 2012 Nov;33(21):2719-47. doi: 10.1093/eurheartj/ehs253. Epub 2012 Aug 24.  

Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation. Goette A, Bukowska A, Lillig CH, Lendeckel U.Front Physiol. 2012;3:236. doi: 10.3389/fphys.2012.00236. Epub 2012 Jul 5.

Nicotine, cigarette smoking and cardiac arrhythmia: an overview. D'Alessandro A, Boeckelmann I, Hammwhöner M, Goette A. Eur J Prev Cardiol. 2012 Jun;19(3):297-305. Review.

Therapy of atrial fibrillation in the critically ill. Willich T, Hammwöhner M, Goette A. Med Klin Intensivmed Notfmed. 2012 Jun;107(5):368-76. doi: 10.1007/s00063-012-0082-5. Epub 2012 Jun 13. German.

Atrial fibrillation and fibrosis: role of connective tissue growth factor. Lendeckel U, Wolke C, Goette A. Europace. 2012 Aug;14(8):1079-80. doi: 10.1093/europace/eus147. Epub 2012 May 22.

Atrial fibrillation: an inflammatory disease or a conformational disorder? Goette A. Can J Cardiol. 2012 Sep-Oct;28(5):529-30. doi: 10.1016/j.cjca.2012.03.016. Epub 2012 May 19.

Outpatient evaluation and management of patients with ventricular premature beats or non-sustained ventricular tachycardia. Svendsen JH, Goette A, Dobreanu D, Marinskis G, Mabo P, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2012 Feb;14(2):294-6. doi: 10.1093/europace/eus009.

Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial. Goette A, Schön N, Kirchhof P, Breithardt G, Fetsch T, Häusler KG, Klein HU, Steinbeck G, Wegscheider K, Meinertz T. Circ Arrhythm Electrophysiol. 2012 Feb;5(1):43-51. doi: 10.1161/CIRCEP.111.965178. Epub 2011 Dec 7.

Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs. Bukowska A, Hammwöhner M, Sixdorf A, Schild L, Wiswedel I, Röhl FW, Wolke C, Lendeckel U, Aderkast C, Bochmann S, Chilukoti RK, Mostertz J, Bramlage P, Goette A. Br J Pharmacol. 2012 Jun;166(3):964-80. doi: 10.1111/j.1476-5381.2011.01784.x.

Neutral effects of statins to prevent atrial fibrillation recurrences after catheter ablation of atrial fibrillation: should we bury upstream therapy for secondary prevention of atrial fibrillation? Goette A.Heart Rhythm. 2012 Feb;9(2):179-80. doi: 10.1016/j.hrthm.2011.09.070. Epub 2011 Oct 12. No abstract available.

Induction of ventricular tachycardia during radiofrequency ablation via pulmonary vein ablation catheter in a patient with an implanted pacemaker. Hammwöhner M, Stachowitz J, Willich T, Goette A. Europace. 2012 Feb;14(2):298-9. doi: 10.1093/europace/eur260. Epub 2011 Aug 15.

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kaab S, Schotten U, Wegscheider K, Boriani G, Brandes A, Ezekowitz M, Diener H, Haegeli L, Heidbuchel H, Lane D, Mont L, Willems S, Dorian P, Aunes-Jansson M, Blomstrom-Lundqvist C, Borentain M, Breitenstein S, Brueckmann M, Cater N, Clemens A, Dobrev D, Dubner S, Edvardsson NG, Friberg L, Goette A, Gulizia M, Hatala R, Horwood J, Szumowski L, Kappenberger L, Kautzner J, Leute A, Lobban T, Meyer R, Millerhagen J, Morgan J, Muenzel F, Nabauer M, Baertels C, Oeff M, Paar D, Polifka J, Ravens U, Rosin L, Stegink W, Steinbeck G, Vardas P, Vincent A, Walter M, Breithardt G, Camm AJ. Europace. 2012 Jan;14(1):8-27. doi: 10.1093/europace/eur241. Epub 2011 Jul 26. Review.

Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF)-Trial. Goette A, Schön N, Kirchhof P, Breithardt G, Fetsch T, Häusler KG, Klein HU, Steinbeck G, Wegscheider K, Meinertz T. Circ Arrhythm Electrophysiol. 2011 Dec 7. [Epub ahead of print]

Neutral effects of statins to prevent atrial fibrillation recurrences after catheter ablation of atrial fibrillation: Should we bury upstream therapy for secondary prevention of atrial fibrillation? Goette A. Heart Rhythm. 2011 Oct 12. [Epub ahead of print] No abstract available.

Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction. Lehmann HI, Goette A, Martens-Lobenhoffer J, Hammwöhner M, Röhl FW, Bukowska A, Ghanem A, Klein HU, Bode-Böger SM. Europace. 2011 Oct;13(10):1428-35. Epub 2011 Jul 13.

Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. Kirchhof P, Nabauer M, Gerth A, Limbourg T, Lewalter T, Goette A, Wegscheider K, Treszl A, Meinertz T, Oeff M, Ravens U, Breithardt G, Steinbeck G; AFNET registry investigators. Thromb Haemost. 2011 Jun 6;105(6):1010-23. Epub 2011 May 5.

The vanishing story of angiotensin II receptor blockers in the treatment of atrial fibrillation. Goette A. Europace. 2011 Apr;13(4):451-2. Epub 2011 Mar 7.

[Techniques for occlusion of the left atrial appendage: chances and risks]. Goette A. Nervenarzt. 2011 Feb;82(2):172, 174-6, 178-9.

Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Schotten U, Verheule S, Kirchhof P, Goette A. Physiol Rev. 2011 Jan;91(1):265-325. Review. Erratum in: Physiol Rev. 2011 Oct;91(4):1533.

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. Aliot E, Capucci A, Crijns HJ, Goette A, Tamargo J. Europace. 2010 Dec 7.

[Heart rhythm disturbances and their treatment according to recent recommendations]. Hammwöhner M, Goette A. Dtsch Med Wochenschr. 2010 Dec;135(49):2461-76.

Physiologic and Pathophysiologic Role of Calpain: Implications for the Occurrence of Atrial Fibrillation. Bukowska A, Lendeckel U, Bode-Böger SM, Goette A. Cardiovasc Ther. 2010 Nov 25. doi: 10.1111/j.1755-5922.2010.00245.x.

The impact of rapid atrial pacing on ADMA and endothelial NOS. Goette A, Hammwöhner M, Bukowska A, Scalera F, Martens-Lobenhoffer J, Dobrev D, Ravens U, Weinert S, Medunjanin S, Lendeckel U, Bode-Böger SM. Int J Cardiol. 2010 Oct 4.

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P; Document Reviewers, Vardas PE, Agladze V, Aliot E, Balabanski T, Blomstrom-Lundqvist C, Capucci A, Crijns H, Dahlöf B, Folliguet T, Glikson M, Goethals M, Gulba DC, Ho SY, Klautz RJ, Kose S, McMurray J, Perrone Filardi P, Raatikainen P, Salvador MJ, Schalij MJ, Shpektor A, Sousa J, Stepinska J, Uuetoa H, Zamorano JL, Zupan I. Europace. 2010 Oct;12(10):1360-420. No abstract available.

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Eur Heart J. 2010 Oct;31(19):2369-429. Epub 2010 Aug 29.

[Registry and studies of the German Competence Network on Atrial Fibrillation (AFNET)] Nabauer M, Gerth A, Kirchhof P, Goette A, Limbourg T, Sprenger C, Hoffmann B, Willems S, Doll N, Schuchert A, Oeff M, Ravens U, Meinertz T, Steinbeck G, Breithardt G. Herzschrittmacherther Elektrophysiol. 2010 Sep;21(3):153-9. German.

Guidelines for the management of atrial Fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA); Endorsed by the European Association for the Cardio-Thoracic Surgery (EACTS); Authors/Task Force Members, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. EUR Heart J 2010 Aug 29.

Registry and studies of the German Competence Network of Atrial Fibrillation (AFNET) Nabauer M, Gerth A, Kirchhof P, Goette A, Limbourg T, Sprenger C, Hoffmann B, Willems S, Doll N, Schuchert A, Oeff M, Ravens U, Meinertz T, Steinbeck G, Breithaupt G. Herzschrittmacherther Elektrophysiol. 2010 Aug 1. [Epub ahead of print] German

Rheumatoid pneumoconiosis (Caplan's syndrome). Schreiber J, Koschel D, Kekow J, Waldburg N, Goette A, Merget R. Eur J Intern Med. 2010 Jun;21(3):168-72. Epub 2010 Mar 2.PMID: 20493416 [PubMed - in process]

Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation. Lendeckel U, Dobrev D, Goette A. Br J Pharmacol. 2010 Apr;159(8):1581-3.PMID: 20388187 [PubMed - in process]

Clinical pharmacology and electrophysiological properties of dronedarone Lewalter T, Pittrow D, Goette A, Kirch W, Hohnloser S. Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S43-7. Epub 2010 Mar 10

Clinical profile of the new antiarrhythmic drug dronedarone Schmitt J, Lewalter T, Pittrow D, Duray G, Goette A, Brachmann J, Hohnloser SH. Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S38-42. Epub 2010 Mar 10.

Current antiarrhythmic drug therapy in atrial fibrillation. Goette A. Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S33-7. Epub 2010 Mar 10.

Recent advances in the pharmacological treatment of cardiac arrythmias Gramley F, Himmrich E, Mollnau H, Theis C, Hammwohner M, Goette A. Drugs Today (Barc). 2009 Nov;45(11):807-24.

Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Girmatsion Z, Biliczki P, Bonauer A, Wimmer-Greinecker G, Scherer M, Moritz A, Bukowska A, Goette A, Nattel S, Hohnloser SH, Ehrlich JR. Heart Rhythm. 2009 Dec;6(12):1802-9. Epub 2009 Sep 3.

Sudden cardiac death stratification in asymptomatic ventricular preexcitation. Cantú F, Goette A; EHRA Scientific Initiatives Committee. Europace. 2009 Nov;11(11):1536-7.

Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes. Kaleschke G, Hoffmann B, Drewitz I, Steinbeck G, Naebauer M, Goette A, Breithardt G, Kirchhof P. Europace. 2009 Oct;11(10):1362-8.

Cardiac-resynchronization therapy for the prevention of heart-failure events. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. MADIT-CRT Trial Investigators.N Engl J Med. 2009 Oct 1;361(14):1329-38. Epub 2009 Sep 1.

Gender and age-dependent differences in the bradykinin-degradation within the pericardial fluid of patients with coronary artery disease. Bechtloff R, Goette A, Bukowska A, Kähne T, Peters B, Huth C, Wolke C, Lendeckel U. Int J Cardiol. 2009 Jul 8. [Epub ahead of print]

Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, Ravens U, Schotten U, Steinbeck G, Vardas P, Waldo A, Wegscheider K, Willems S, Breithardt G. Eur Heart J. 2009 Dec;30(24):2969-77c. Epub .

Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, Ravens U, Schotten U, Steinbeck G, Vardas P, Waldo A, Wegscheider K, Willems S, Breithardt G. Europace. 2009 Jul;11(7):860-85. Epub 2009 Jun 16. No abstract available.

Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke? Goette A. Cardiovasc Res. 2009 Aug 1;83(3):421-2. Epub 2009 Jun 5. No abstract available.

The effects of G-CSF-induced mobilization of progenitor cells are limited by ADMA. Goette A, Wolfram O, Jentsch-Ullrich K, Martens-Lobenhoffer J, Scalera F, Lendeckel U, Bode-Böger SM. Int J Cardiol. 2009 Mar 19. [Epub ahead of print]

Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Goette A, Bukowska A, Dobrev D, Pfeiffenberger J, Morawietz H, Strugala D, Wiswedel I, Röhl FW, Wolke C, Bergmann S, Bramlage P, Ravens U, Lendeckel U. Eur Heart J. 2009 Jun;30(11):1411-20. Epub 2009 Mar 5.

Severe mitral regurgitation in a patient with a bluish right sclera: an 'extension' of Caplan's syndrome to the heart and eye. Goette A, Huth C, Behrens-Baumann W, Evert M. Eur J Intern Med. 2009 Jan;20(1):e1-2. Epub 2008 Mar 4. No abstract available.

Atrial expression of endothelial nitric oxide synthase in patients with and without atrial fibrillation. Bukowska A, Röcken C, Erxleben M, Röhl FW, Hammwöhner M, Huth C, Ebert MP, Lendeckel U, Goette A. Cardiovasc Pathol. 2009 Feb 10. [Epub ahead of print]

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, Goette A, Lewalter T, Ravens U, Meinertz T, Breithardt G, Steinbeck G. Europace. 2009 Apr;11(4):423-34. Epub 2009 Jan 18

The German Competence Network on Atrial Fibrillation (AFNET). Breithardt G, Dobrev D, Doll N, Goette A, Hoffmann B, Kirchhof P, Köster I, Kuck KH, Leute A, Meinertz T, Näbauer M, Oeff M, Ravens U, Schuchert A, Sprenger C, Steinbeck G, Willems S. Herz. 2008 Dec;33(8):548-55.

Performance and survival of transvenous defibrillation leads: need for a European data registry. Goette A, Cantu F, van Erven L, Geelen P, Halimi F, Merino JL, Morgan JM; Scientific Initiative Committee of the European Heart Rhythm Association. Europace. 2009 Jan;11(1):31-4. Epub 2008 Nov 11.